Post hoc LUCENT-2 and VIVID-1 analyses show more mirikizumab-treated patients reached steroid-free composite remission in UC ...
The American College of Obstetricians & Gynecologists (ACOG) has published new clinical guidance on managing menopause-related vasomotor symptoms (VMS), sleep disturbance, and moo ...
For primary care physicians, the question is increasingly whether continuous glucose data could answer a clinically useful ...
The US Food and Drug Administration (FDA) has granted Breakthrough Device designation to Natera's multi-cancer early ...
Pauline M. Maki, PhD, reviews the first data cuts from OPTION-VMS, released at The Menopause Society 2025 meeting. These ...
Pauline M. Maki, PhD, introduces OPTION-VMS and explains why real-world data are needed to test whether randomized trial ...
Adolescents and young adults with sporadic colorectal cancer (CRC) most often present with stage III or IV disease, and only ...
Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood ...
Every clinician can prescribe or refer for PrEP. The faculty outline the education, team structures, and community outreach ...
A gap between perceived and actual risk, messaging that has not reached women, and long drive times to a prescriber all limit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results